General Information
Version
1.0
Revision date
2026-05-27
Product name
501056 Ethylene Brassylate
Substance name
501056 Ethylene Brassylate
Product Synonyms
1,4-Dioxacycloheptadecane-5,17-dione / ethylene glycol brassylate / ethylene undecanedicarboxylate
Chemical name
Ethylene brassylate
CAS No.
105-95-3
1.2.1 Relevant identified uses
Concentrated aromatic and flavor ingredient which may be used in flavor and fragrance compounds according to legal and IFRA or FEMA GRAS/FDA guidelines
1.2.2. Uses advised against
For Manufacturing Use Only
supplier name
Vigon International, LLC
Emergency telephone
+44 1235 239670, +1 800 579 7421, +65 3158 1074, 1235 239671, +44 1865 407333, +1 202 464 2554
Icons in SDS
Company Information
company name
Vigon International, LLC
e-mail address of the competent person responsible for the Safety Data Sheet
regulatory@vigon.com
Hazard Codes
Hazard statements (CLP)
H401, H412
Hazard statements
Code
Statements
H401
Toxic to aquatic life
Section 2
SECTION 2: Hazards identification
Classification of the substance or mixture GHS US classification Aquatic Acute 2 H401 Toxic to aquatic life Aquatic Chronic 3 H412 Harmful to aquatic life with long lasting effects Full text of hazard classes and H-statements see section 16
2.2 Label elements
GHS US labelling
Hazard statements
H401 - Toxic to aquatic life H412 - Harmful to aquatic life with long lasting effects
Precautionary statements
P273 - Avoid release to the environment. P220 - Keep/Store away from incompatible materials. P501 - Dispose of contents and/or container to in accordance with local authority requirements. 2.3. Hazards associated with known or reasonably anticipated uses No additional information available
2.3 Other hazards
No additional information available 2.5. Unknown acute toxicity No additional information available
2.1 Classification of the substance or mixture
GHS US classification Aquatic Acute 2 H401 Toxic to aquatic life. Aquatic Chronic 3 H412 Harmful to aquatic life with long lasting effects. Full text of hazard classes and H-statements : see section 16
